Press release
Personal Care
February 18, 2011

Powerful Innovations for Beauty & Wellness at PCHi 2011

Evonik Industries is presenting its portfolio of Personal Care products and silica products at this year’s PCHi in Shenzen, China, with focus on innovative products and technologies for skin and hair care, as well as cosmetic applications.

- Living up to Corporate Responsibility, Evonik is providing products based on renewable raw materials

- PCHi 2011 (Feb 22-24 in Shenzhen), Evonik Booth No: B 50

TEGO® Pep 4-Even is the first tetrapeptide which treats hyperpigmentation
Several in vivo studies on Caucasian skin have proven that age spots on the face and hands are diminished with the use of TEGO® Pep 4-Even. An in vivo study on Asian skin has shown that the building of melanin is slowed down, but not completely stopped, as it is important for healthy skin that the pigmentation process is not completely deactivated. A clinical study on ethnic skin (Fitzpatrick skin type IV-V) further supports the peptide’s anti-aging activity, by showing the diminished appearance of dark spots and discolorations.

HyaCare® Filler CL – the topical wrinkle smoother
HyaCare® Filler CL, one of our anti-aging specialties based on Hyaluronic Acid, contributes instantly to the reduction of facial wrinkles and fine lines, as well as increasing the elasticity of the skin.
Because of its high water-binding and strong short-term moisturization properties, HyaCare® Filler CL supports effectively the hydration of the skin. It can be used for all anti-aging applications where an instant effect, as well as moisturization, is desired.

TEGO® Care PSC 3 - the vegetable-based emulsifier
TEGO® Care PSC 3 (INCI: Polyglyceryl-3 Dicitrate/ Stearate) is a PEG-free, purely vegetable-based emulsifier that provides mildness, high performance and versatility, and makes it possible to achieve an excellent cost-performance ratio in oil-in-water creams and lotions. Forming stable emulsions over a wide pH range, TEGO® Care PSC 3 allows formulators to use organic acids as preservatives. It is based 100 percent on natural raw materials: glycerine, stearic acid, and citric acid. It eliminates the need to incorporate polyacrylate thickeners as stabilizers.

AEROSIL® – more than just a powder
AEROSIL ® products are recognized in the personal care industry for their versatility and effectiveness, whether used to improve existing formulations or to develop new ones. Our products are characterized by their high purity and chemical inertness, which are especially important in cosmetic applications.

SIPERNAT® and SIDENT® Precipitated Silica
Evonik is a leading supplier of precipitated silica, which is used as a reinforcing filler or carrier in a diverse range of applications. SIPERNAT® synthetically manufactured silica is a fine, loose, white powder. It has versatile properties that make production processes and final products more efficient and may be used in many types of personal care applications, such as toothpaste, antiperspirant, and lipstick, etc.

In addition to the presentation of the highlights of its new portfolio, Evonik will be present three lectures at the PCHi Technical Innovation Conference about our novel methods and ingredients for cosmetic formulators. The topics include “A new method to prepare low viscosity but stable W/O systems”, “Development of New Emollients as Natural, Sustainable and High Performance Solutions”, and “A new, versatile and cost-efficient O/W emulsifier for natural cosmetics and beyond”.


About Evonik

Evonik Industries is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company’s performance is shaped by creativity, specialization, continuous self-renewal, and reliability.
Evonik is active in over 100 countries around the world. In its fiscal year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.